Poland· PL-100525837
Ekterly
A drugs used in hereditary angioedema product containing sebetralstat, registered in Poland by KalVista Pharmaceuticals (Ireland) Ltd.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sebetralstat is registered in 2 of 19 countries.
Countries holding a registration under ATC B06AC (drugs used in hereditary angioedema), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 1 of them publish a price we can compare per daily dose
Sebetralstat · ATC B06AC
2 / 19 countries
- Denmark
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Sebetralstat
- Manufacturer
- KalVista Pharmaceuticals (Ireland) Ltd.
- Country
- Poland (PL)
- ATC code
- B06AC
- ATC class
- Drugs used in hereditary angioedema
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sebetralstat in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEKTERLYKalVista Pharmaceuticals (Ireland) Ltd., Dublin
- SwitzerlandEkterly 300 mg, FilmtablettenKalVista Pharmaceuticals Switzerland GmbH
- IrelandEkterly 300 mg film-coated tabletsKalvista Pharmaceuticals (Ireland) Limited
- IcelandEkterlyKalvista Pharmaceuticals (Ireland) Limited
- NetherlandsEkterly 300 mg filmomhulde tablettenKalvista Pharmaceuticals (Ireland) Limited
- BelgiumEkterly 300 mgKalvista Pharmaceuticals (Ireland)
- SwedenEkterly 300 mg Filmdragerad tablettKalvista Pharmaceuticals (Ireland) Limited
- FinlandEkterlyKalvista Pharmaceuticals (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ekterly
- Liechtenstein · Ekterly
- Norway · Ekterly
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/595a1c1a-8054-4882-9021-e498bd165d35 GET /v1/drugs/595a1c1a-8054-4882-9021-e498bd165d35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "300 mg",
"packaging": "Rp ¦ EU/1/25/1975/001 ¦ 163933\n4 tabl.\nRp ¦ EU/1/25/1975/002 ¦ 163934\n6 tabl.",
"substance": "Sebetralstat 300 mg",
"common_name": "Sebetralstat",
"pl_product_id": "100525837",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about sebetralstat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.